We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) is anticipated to release its earnings data before the market opens on ...

Sangamo Therapeutics, Inc.’s SGMO share price has dipped by 20.19%, which has investors questioning if this is right time to ...

R&D Expenses: Research and development expenses for the year ended December 31, 2024 were $38.8 million, compared to $40.6 million for the year ended December 31, 2023. The decrease was primarily due ...

94.08% of the stock is currently owned by institutional investors. United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address ...

in metastatic breast cancer and recommended continuation of the ongoing study without any modifications. BriaCell Therapeutics Corp shares T.BCT are trading up $0.31 at $6.45.

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm thinks the challenges to owning United in 2025 are ...

SILEXION THERAPEUTICS CORP CONSOLIDATED STATEMENTS OF OPERATIONS (U.S. dollars in thousands, except share data) Year ended December 31 2024 2023 OPERATING EXPENSES: Research and development ...

What is the current share price of United Therapeutics Corp (UTHR)? United Therapeutics Corp's (UTHR) current share price is $307.24. This constitutes a price movement of 0.04% when compared to the ...